$HCAT
Health Catalyst, Inc. Stock $hcat

$hcat Overview Financials Valuation SEC Filings Company Website

2019 Q3 Form 10-Q Financial Statement

#000163642219000013 Filed on August 23, 2019

Income Statement

Concept	2019 Q3	2019 Q2	2018 Q2
Revenue	$39.42M	$36.80M	$22.99M
YoY Change	19.94%	60.09%	31.07%
Cost Of Revenue	$18.63M	$17.71M	$12.52M
YoY Change	9.59%	41.45%	7.38%
Gross Profit	$20.79M	$19.09M	$10.47M
YoY Change	31.0%	82.33%	77.76%
Gross Profit Margin	52.74%	51.87%	45.54%
Selling, General & Admin	$25.73M	$16.53M	$19.25M
YoY Change	32.81%	-14.1%	87.03%
% of Gross Profit	123.78%	86.6%	183.81%
Research & Development	$13.48M	$9.710M	$8.487M
YoY Change	24.34%	14.41%	24.81%
% of Gross Profit	64.82%	50.86%	81.06%
Depreciation & Amortization	$700.0K	$700.0K	$400.0K
YoY Change	0.0%	75.0%	-74.03%
% of Gross Profit	3.37%	3.67%	3.82%
Operating Expenses	$41.53M	$28.46M	$29.28M
YoY Change	28.3%	-2.82%	57.27%
Operating Profit	-$20.74M	-$9.363M	-$18.81M
YoY Change	25.71%	-50.23%	47.77%
Interest Expense	-$660.0K	-$1.340M	-$510.0K
YoY Change	78.38%	162.75%	54.55%
% of Operating Profit
Other Income/Expense, Net	$0.00	$20.00K
YoY Change
Pretax Income	-$21.40M	-$10.68M	-$19.32M
YoY Change	26.85%	-44.72%	47.82%
Income Tax	$21.00K	$11.00K	$7.000K
% Of Pretax Income
Net Earnings	-$21.42M	-$10.69M	-$19.32M
YoY Change	26.9%	-44.66%	47.74%
Net Earnings / Revenue	-54.32%	-29.06%	-84.05%
Basic Earnings Per Share
Diluted Earnings Per Share	-$759.0K	-$304.7K	-$550.7K
COMMON SHARES
Basic Shares Outstanding	36.49M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2019 Q3	2019 Q2	2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$241.4M	$54.10M
YoY Change
Cash & Equivalents	$52.06M	$20.82M	$29.30M
Short-Term Investments	$189.4M	$33.30M
Other Short-Term Assets	$7.400M	$6.400M
YoY Change
Inventory
Prepaid Expenses
Receivables	$31.02M	$34.47M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$279.8M	$95.03M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$4.228M	$4.180M
YoY Change
Goodwill	$3.694M	$3.694M
YoY Change
Intangibles	$26.68M	$27.54M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.050M	$4.041M
YoY Change
Total Long-Term Assets	$40.15M	$44.65M
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$279.8M	$95.03M
Total Long-Term Assets	$40.15M	$44.65M
Total Assets	$320.0M	$139.7M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.179M	$3.035M
YoY Change
Accrued Expenses	$12.30M	$10.90M
YoY Change
Deferred Revenue	$32.13M	$34.41M
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00
YoY Change
Total Short-Term Liabilities	$53.05M	$50.51M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt	$47.92M	$47.64M
YoY Change
Other Long-Term Liabilities	$687.0K	$652.0K
YoY Change
Total Long-Term Liabilities	$48.60M	$48.29M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$53.05M	$50.51M
Total Long-Term Liabilities	$48.60M	$48.29M
Total Liabilities	$113.4M	$112.3M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings	-$596.2M	-$557.2M
YoY Change
Common Stock	$36.00K	$5.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$206.6M	-$557.1M	-$282.6M
YoY Change
Total Liabilities & Shareholders Equity	$320.0M	$139.7M
YoY Change

Cashflow Statement

Concept	2019 Q3	2019 Q2	2018 Q2
OPERATING ACTIVITIES
Net Income	-$21.42M	-$10.69M	-$19.32M
YoY Change	26.9%	-44.66%	47.74%
Depreciation, Depletion And Amortization	$700.0K	$700.0K	$400.0K
YoY Change	0.0%	75.0%	-74.03%
Cash From Operating Activities	-$5.480M	-$8.420M	-$14.02M
YoY Change	-7.12%	-39.94%
INVESTING ACTIVITIES
Capital Expenditures	-$1.370M	-$950.0K	-$190.0K
YoY Change	470.83%	400.0%
Acquisitions
YoY Change
Other Investing Activities	-$156.0M	-$600.0K	$2.380M
YoY Change	-2721.18%	-125.21%
Cash From Investing Activities	-$157.3M	-$1.550M	$2.190M
YoY Change	-2855.17%	-170.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	194.0M	-1.420M	22.96M
YoY Change	-19504.0%	-106.18%
NET CHANGE
Cash From Operating Activities	-5.480M	-8.420M	-14.02M
Cash From Investing Activities	-157.3M	-1.550M	2.190M
Cash From Financing Activities	194.0M	-1.420M	22.96M
Net Change In Cash	31.24M	-11.39M	11.13M
YoY Change	-2725.21%	-202.34%
FREE CASH FLOW
Cash From Operating Activities	-$5.480M	-$8.420M	-$14.02M
Capital Expenditures	-$1.370M	-$950.0K	-$190.0K
Free Cash Flow	-$4.110M	-$7.470M	-$13.83M
YoY Change	-27.39%	-45.99%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	7306000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
	dei	Entity Central Index Key EntityCentralIndexKey	0001636422
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4779356	shares
CY2019Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5002426	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4779356	shares
CY2019Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5002426	shares
CY2018Q4	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	0	USD
CY2018Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	Sergment
CY2018Q4	us-gaap	Shares Issued SharesIssued	4832134	shares
CY2019Q2	us-gaap	Shares Issued SharesIssued	5055204	shares
CY2018Q4	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	306000	USD
CY2019Q2	us-gaap	Temporary Equity Liquidation Preference TemporaryEquityLiquidationPreference	318000	USD
CY2018Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2019Q2	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Entity Address Address Line1 EntityAddressAddressLine1	3165 Millrock Drive #400
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38993
	dei	Local Phone Number LocalPhoneNumber	708-6800
	dei	Document Period End Date DocumentPeriodEndDate	2019-06-30
	dei	Entity Registrant Name EntityRegistrantName	HEALTH CATALYST, INC.
	dei	Trading Symbol TradingSymbol	HCAT
	hcat	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	1096000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13641000	USD
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Address City Or Town EntityAddressCityOrTown	Salt Lake City
	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
	dei	Entity Shell Company EntityShellCompany	false
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	45-3337483
	dei	City Area Code CityAreaCode	801
CY2019Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	36494678	shares
	dei	Entity Address State Or Province EntityAddressStateOrProvince	UT
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	84121
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2019Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20819000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28431000	USD
CY2019Q2	us-gaap	Short Term Investments ShortTermInvestments	33257000	USD
CY2018Q4	us-gaap	Short Term Investments ShortTermInvestments	4761000	USD
CY2019Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	34472000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	27696000	USD
CY2019Q2	us-gaap	Deferred Costs Current DeferredCostsCurrent	845000	USD
CY2018Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	649000	USD
CY2019Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5632000	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5321000	USD
CY2019Q2	us-gaap	Assets Current AssetsCurrent	95025000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	66858000	USD
CY2019Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4180000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4676000	USD
CY2019Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	27538000	USD
CY2018Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	28304000	USD
CY2019Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5198000	USD
CY2018Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6344000	USD
CY2019Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4041000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1099000	USD
CY2019Q2	us-gaap	Goodwill Goodwill	3694000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	3694000	USD
CY2019Q2	us-gaap	Assets Assets	139676000	USD
CY2018Q4	us-gaap	Assets Assets	110975000	USD
CY2019Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3035000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1812000	USD
CY2019Q2	hcat	Accrued Liabilities And Employee Related Liabilities Current AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent	8107000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	7280000	USD
CY2018Q4	hcat	Accrued Liabilities And Employee Related Liabilities Current AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent	9203000	USD
CY2019Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	2200000	USD
CY2018Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	2172000	USD
CY2019Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	34405000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	24755000	USD
CY2019Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2761000	USD
CY2018Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2577000	USD
CY2019Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2018Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1287000	USD
CY2019Q2	us-gaap	Liabilities Current LiabilitiesCurrent	50508000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	41806000	USD
CY2019Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	47635000	USD
CY2018Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	18814000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	75898000	USD
CY2019Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	2944000	USD
CY2019Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3206000	USD
CY2018Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4228000	USD
CY2019Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	652000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0	USD
CY2018Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	3770000	USD
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	5000	USD
CY2019Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	0	USD
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	0	USD
CY2019Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-557163000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-374772000	USD
CY2019Q2	us-gaap	Liabilities Liabilities	112251000	USD
CY2019Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	9000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1000	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	-557149000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	-374768000	USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	584574000	USD
CY2018Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	409845000	USD
CY2019Q2	us-gaap	Common Stock Value CommonStockValue	5000	USD
CY2019Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	139676000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	110975000	USD
CY2019Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	36804000	USD
CY2018Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22990000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	72017000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	43622000	USD
CY2019Q2	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	17710000	USD
CY2018Q2	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	12518000	USD
	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	35036000	USD
	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	24128000	USD
CY2019Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	10385000	USD
CY2018Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	12004000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	20858000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	18725000	USD
CY2019Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9710000	USD
CY2018Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8487000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	19732000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17192000	USD
CY2019Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6146000	USD
CY2018Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7241000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12320000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11143000	USD
CY2019Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2216000	USD
CY2018Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1551000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4528000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3101000	USD
CY2019Q2	us-gaap	Operating Expenses OperatingExpenses	28457000	USD
CY2018Q2	us-gaap	Operating Expenses OperatingExpenses	29283000	USD
	us-gaap	Operating Expenses OperatingExpenses	57438000	USD
	us-gaap	Operating Expenses OperatingExpenses	50161000	USD
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-9363000	USD
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-18811000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-20457000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-30667000	USD
CY2019Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2018Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1670000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2019Q2	hcat	Interest And Other Expense Net InterestAndOtherExpenseNet	1320000	USD
CY2018Q2	hcat	Interest And Other Expense Net InterestAndOtherExpenseNet	506000	USD
	hcat	Interest And Other Expense Net InterestAndOtherExpenseNet	2265000	USD
	hcat	Interest And Other Expense Net InterestAndOtherExpenseNet	1015000	USD
CY2019Q2	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-10683000	USD
CY2018Q2	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-19317000	USD
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-24392000	USD
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-31682000	USD
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	11000	USD
CY2018Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	22000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-149000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-10694000	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	-19324000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-24414000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-31533000	USD
CY2019Q2	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	98641000	USD
CY2018Q2	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-2078000	USD
	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	162656000	USD
	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-12559000	USD
CY2019Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-109335000	USD
CY2018Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-17246000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-187070000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-18974000	USD
CY2019Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-21.98
CY2018Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-3.53
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-38.29
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-3.89
CY2019Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	4975000	shares
CY2018Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	4888000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	4885000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	4878000	shares
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-10694000	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	-19324000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	-450036000	USD
CY2019Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	817000	USD
CY2019Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10687000	USD
CY2018Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-19310000	USD
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1398000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	7000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-24414000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-31533000	USD
CY2019Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	23151481	shares
CY2019Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	485933000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	14000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	10000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-24404000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-31534000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-10694000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	7000	USD
CY2019Q2	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	98641000	USD
CY2019Q2	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	98641000	USD
CY2019Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	23151481	shares
CY2019Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	584574000	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	-557149000	USD
CY2018Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	22713694	shares
CY2018Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	409845000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	-374768000	USD
	hcat	Temporary Equity Stock Issued During Period Shares New Issues TemporaryEquityStockIssuedDuringPeriodSharesNewIssues	437787	shares
	us-gaap	Temporary Equity Stock Issued During Period Value New Issues TemporaryEquityStockIssuedDuringPeriodValueNewIssues	12073000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1625000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3054000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-24414000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	10000	USD
	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	162656000	USD
	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	162656000	USD
CY2019Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	23151481	shares
CY2019Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	584574000	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	-557149000	USD
CY2018Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	21298468	shares
CY2018Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	315085000	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	-260090000	USD
CY2018Q2	hcat	Temporary Equity Stock Issued During Period Shares New Issues TemporaryEquityStockIssuedDuringPeriodSharesNewIssues	1415226	shares
CY2018Q2	us-gaap	Temporary Equity Stock Issued During Period Value New Issues TemporaryEquityStockIssuedDuringPeriodValueNewIssues	32242000	USD
CY2018Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	8712000	USD
CY2018Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2506000	USD
CY2018Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	914000	USD
CY2018Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	345249000	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	-19324000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	14000	USD
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	-282614000	USD
CY2018Q2	hcat	Temporary Equity Decrease In Carrying Amount Of Redeemable Preferred Stock TemporaryEquityDecreaseInCarryingAmountOfRedeemablePreferredStock	2078000	USD
CY2018Q2	us-gaap	Increase In Carrying Amount Of Redeemable Preferred Stock IncreaseInCarryingAmountOfRedeemablePreferredStock	2078000	USD
CY2018Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	22713694	shares
CY2017Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	21109771	shares
CY2017Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	321569000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	-259475000	USD
	hcat	Temporary Equity Stock Issued During Period Shares New Issues TemporaryEquityStockIssuedDuringPeriodSharesNewIssues	1603923	shares
	us-gaap	Temporary Equity Stock Issued During Period Value New Issues TemporaryEquityStockIssuedDuringPeriodValueNewIssues	36239000	USD
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	8712000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2594000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1954000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-31533000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1000	USD
	hcat	Temporary Equity Decrease In Carrying Amount Of Redeemable Preferred Stock TemporaryEquityDecreaseInCarryingAmountOfRedeemablePreferredStock	12559000	USD
	us-gaap	Increase In Carrying Amount Of Redeemable Preferred Stock IncreaseInCarryingAmountOfRedeemablePreferredStock	12559000	USD
CY2018Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	22713694	shares
CY2018Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	345249000	USD
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	-282614000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-24414000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-31533000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4528000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3101000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1670000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	516000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	258000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	274000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	74000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-35000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	34000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	15000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	3054000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1954000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6776000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2825000	USD
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	196000	USD
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-358000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	55000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1500000	USD
	hcat	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	-1146000	USD
	hcat	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	1239000	USD
	hcat	Increase Decrease In Accounts Payable Accrued Liabilities And Other Liabilities IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndOtherLiabilities	-1644000	USD
	hcat	Increase Decrease In Accounts Payable Accrued Liabilities And Other Liabilities IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndOtherLiabilities	2810000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	9676000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	18000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-30214000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	10997000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1063000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	521000	USD
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	14200000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	977000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	38000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	15000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	40509000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	6237000	USD
	hcat	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-838000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	2679000	USD
	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	12297000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-21407000	USD
	us-gaap	Proceeds From Issuance Of Redeemable Preferred Stock ProceedsFromIssuanceOfRedeemablePreferredStock	12073000	USD
	us-gaap	Proceeds From Issuance Of Redeemable Preferred Stock ProceedsFromIssuanceOfRedeemablePreferredStock	33987000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1625000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2594000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	8712000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	21821000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	47169000	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	USD
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	773000	USD
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	11136000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	2030000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	36243000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	16733000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-7612000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	6323000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28431000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22978000	USD
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20819000	USD
CY2018Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	29301000	USD
	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	162656000	USD
	us-gaap	Increase In Carrying Amount Of Redeemable Preferred Stock IncreaseInCarryingAmountOfRedeemablePreferredStock	12559000	USD
	hcat	Deferred Offering Costs Included In Accounts Payable And Accrued Liabilities DeferredOfferingCostsIncludedInAccountsPayableAndAccruedLiabilities	1168000	USD
	hcat	Deferred Offering Costs Included In Accounts Payable And Accrued Liabilities DeferredOfferingCostsIncludedInAccountsPayableAndAccruedLiabilities	0	USD
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	0	USD
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	2252000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	1304000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	0	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	10000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	15000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	1605000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	1171000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	581000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2182000	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="line-height:120%;padding-bottom:16px;padding-top:0px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of estimates</span></div><div style="line-height:120%;padding-bottom:16px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:24px;font-size:10pt;"><span style="font-family:Times New Roman;font-size:10pt;color:#000000;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an on-going basis, we evaluate our estimates, including those related to revenue recognition, provisions for doubtful accounts, useful lives of property and equipment, capitalization and estimated useful life of internal-use software and other intangible assets, fair value of financial instruments, deferred tax assets, common stock warrants, redeemable convertible preferred stock accretion, stock-based compensation, and tax uncertainties. Actual results could differ from those estimates.</span></div>
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2019Q2	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	3300000	USD
CY2018Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	3400000	USD
CY2019Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	41700000	USD
CY2018Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	32000000.0	USD
CY2019Q2	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	800000	USD
CY2018Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	600000	USD
CY2019Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	400000	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	500000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	15643000	USD
CY2019Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2019Q2	us-gaap	Deferred Offering Costs DeferredOfferingCosts	3200000	USD
CY2018Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	100000	USD
CY2019Q2	us-gaap	Advertising Expense AdvertisingExpense	400000	USD
CY2018Q2	us-gaap	Advertising Expense AdvertisingExpense	600000	USD
	us-gaap	Advertising Expense AdvertisingExpense	1100000	USD
	us-gaap	Advertising Expense AdvertisingExpense	1100000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	28304000	USD
CY2019Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	36804000	USD
CY2018Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22990000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	72017000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	43622000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2019Q2	us-gaap	Goodwill Goodwill	3694000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	3694000	USD
CY2019Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	46227000	USD
CY2019Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	18689000	USD
CY2019Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	27538000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	43947000	USD
CY2019Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1500000	USD
CY2018Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1200000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3000000.0	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2300000	USD
CY2019Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	13246000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12370000	USD
CY2019Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9066000	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7694000	USD
CY2019Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4180000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4676000	USD
CY2019Q2	us-gaap	Depreciation Depreciation	700000	USD
CY2018Q2	us-gaap	Depreciation Depreciation	400000	USD
	us-gaap	Depreciation Depreciation	1500000	USD
	us-gaap	Depreciation Depreciation	800000	USD
CY2019Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	53931000	USD
CY2019Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	9000	USD
CY2019Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2019Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	53940000	USD
CY2018Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	32234000	USD
CY2018Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2018Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	32233000	USD
CY2019Q2	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	0	USD
CY2019Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3903000	USD
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5888000	USD
CY2019Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4204000	USD
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3315000	USD
CY2019Q2	hcat	Accrued Liabilities And Employee Related Liabilities Current AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent	8107000	USD
CY2018Q4	hcat	Accrued Liabilities And Employee Related Liabilities Current AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent	9203000	USD
CY2019Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	2400000	USD
CY2019Q2	us-gaap	Line Of Credit LineOfCredit	50000000	USD
CY2019Q2	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	30000000	USD
CY2019Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	USD
CY2019Q2	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	50000000	USD
CY2018Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	1200000	USD
CY2018Q4	us-gaap	Line Of Credit LineOfCredit	21321000	USD
CY2018Q4	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	18679000	USD
CY2018Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1321000	USD
CY2018Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	20000000	USD
CY2016Q2	hcat	Lineof Credit Formula Percentage Of Eligible Account Balances LineofCreditFormulaPercentageOfEligibleAccountBalances	0.85
CY2019Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	73642899	shares
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	72565312	shares
CY2019Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q2	us-gaap	Shares Outstanding SharesOutstanding	5055204	shares
CY2018Q4	us-gaap	Shares Outstanding SharesOutstanding	4832134	shares
CY2019Q2	hcat	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Non Recourse ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNonRecourse	52778	shares
CY2019Q2	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	31717986	shares
CY2018Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	31503240	shares
CY2019Q2	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	46505028	shares
CY2018Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	45427441	shares
CY2018Q4	us-gaap	Temporary Equity Value Excluding Additional Paid In Capital TemporaryEquityValueExcludingAdditionalPaidInCapital	0.001	USD
CY2019Q2	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	23151481	shares
CY2018Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	22713694	shares
CY2019Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	584600000	USD
CY2018Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	409800000	USD
CY2019Q2	hcat	Temporary Equity Threshold Of Ownership Percentage Of Outstanding Shares TemporaryEquityThresholdOfOwnershipPercentageOfOutstandingShares	0.75
CY2019Q2	hcat	Temporary Equity Indebtedness Threshold TemporaryEquityIndebtednessThreshold	1000000.0	USD
CY2019Q2	hcat	Temporary Equity Total Indebtedness Threshold TemporaryEquityTotalIndebtednessThreshold	5000000.0	USD
CY2019Q2	hcat	Temporary Equity Acquisition Or Investment Threshold TemporaryEquityAcquisitionOrInvestmentThreshold	2000000.0	USD
CY2019Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-109335000	USD
CY2018Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-17246000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-187070000	USD
CY2018	hcat	Share Based Payment Arrangement Expense To Be Recognized Had Performance Conditions Been Satisfied Period Of Recognition ShareBasedPaymentArrangementExpenseToBeRecognizedHadPerformanceConditionsBeenSatisfiedPeriodOfRecognition	P2Y
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-18974000	USD
CY2019Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	4974515	shares
CY2018Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	4888226	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	4885350	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	4877572	shares
CY2019Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-21.98
CY2018Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-3.53
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-38.29
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-3.89
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	31476215	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	27507677	shares
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	8772878	shares
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	241771	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	8772878	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1296793	shares
CY2019Q2	hcat	Sharebased Compensation Arrangement By Share Based Payment Award Options And Non Options Number Of Awards Outstanding SharebasedCompensationArrangementByShareBasedPaymentAwardOptionsAndNonOptionsNumberOfAwardsOutstanding	2300000	shares
CY2018Q4	hcat	Sharebased Compensation Arrangement By Share Based Payment Award Options And Non Options Number Of Awards Outstanding SharebasedCompensationArrangementByShareBasedPaymentAwardOptionsAndNonOptionsNumberOfAwardsOutstanding	1700000	shares
CY2019Q2	hcat	Share Based Payment Arrangement Catch Up Expense Had Performance Conditions Been Satisfied ShareBasedPaymentArrangementCatchUpExpenseHadPerformanceConditionsBeenSatisfied	5300000	USD
CY2019Q2	hcat	Share Based Payment Arrangement Expense To Be Recognized Had Performance Conditions Been Satisfied ShareBasedPaymentArrangementExpenseToBeRecognizedHadPerformanceConditionsBeenSatisfied	10000000.0	USD
	hcat	Share Based Payment Arrangement Expense To Be Recognized Had Performance Conditions Been Satisfied Period Of Recognition ShareBasedPaymentArrangementExpenseToBeRecognizedHadPerformanceConditionsBeenSatisfiedPeriodOfRecognition	P1Y9M18D
CY2018Q4	hcat	Share Based Payment Arrangement Catch Up Expense Had Performance Conditions Been Satisfied ShareBasedPaymentArrangementCatchUpExpenseHadPerformanceConditionsBeenSatisfied	1400000	USD
CY2018Q4	hcat	Share Based Payment Arrangement Expense To Be Recognized Had Performance Conditions Been Satisfied ShareBasedPaymentArrangementExpenseToBeRecognizedHadPerformanceConditionsBeenSatisfied	7300000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1198121	shares
CY2019Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1398000	USD
CY2018Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	914000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3054000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1954000	USD
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.438
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.476
CY2019Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M18D
CY2018Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M18D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M18D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M18D
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.024
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.028
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7237417	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.60
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	180570	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	10.47
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	16.00
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	223070	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	7.28
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8031898	shares
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.60
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y9M18D
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	117262146	USD
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	8031898	shares
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	10.60
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y9M18D
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	117262146	USD
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3246277	shares
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	8.40
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y
CY2019Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	54547254	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	9.31
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	2100000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	2000000.0	USD
CY2019Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	13700000	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y
CY2019Q2	hcat	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Non Recourse ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNonRecourse	52778	shares
CY2019Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0010
CY2018Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0004
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0009
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0047
CY2019Q2	hcat	Contract With Customer Liability Revenue Recognized Percentage ContractWithCustomerLiabilityRevenueRecognizedPercentage	0.37
CY2018Q2	hcat	Contract With Customer Liability Revenue Recognized Percentage ContractWithCustomerLiabilityRevenueRecognizedPercentage	0.24
	hcat	Contract With Customer Liability Revenue Recognized Percentage ContractWithCustomerLiabilityRevenueRecognizedPercentage	0.24
	hcat	Contract With Customer Liability Revenue Recognized Percentage ContractWithCustomerLiabilityRevenueRecognizedPercentage	0.16
CY2019Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	63900000	USD
CY2019Q2	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.86
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2019Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	36804000	USD
CY2018Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22990000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	72017000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	43622000	USD
CY2019Q2	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-10683000	USD
CY2018Q2	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-19317000	USD
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-24392000	USD
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-31682000	USD
CY2019Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	584574000	USD
CY2019Q2	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	54076000	USD
CY2019Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q2	us-gaap	Common Stock Value CommonStockValue	5000	USD
CY2019Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	0	USD
CY2019Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-557163000	USD
CY2019Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	9000	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	-557149000	USD

Files In Submission

Name	View Source	Status
0001636422-19-000013-index-headers.html	Edgar Link	pending
0001636422-19-000013-index.html	Edgar Link	pending
0001636422-19-000013.txt	Edgar Link	pending
0001636422-19-000013-xbrl.zip	Edgar Link	pending
a2019q2hcat10-q.htm	Edgar Link	pending
a2019q2hcat10-q_htm.xml	Edgar Link	completed
exhibit101-10qxnonxemp.htm	Edgar Link	pending
exhibit311-10qxcertifi.htm	Edgar Link	pending
exhibit312-10qxcertifi.htm	Edgar Link	pending
exhibit321-10qxcertifi.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
hcat-20190630.xsd	Edgar Link	pending
hcat-20190630_cal.xml	Edgar Link	unprocessable
hcat-20190630_def.xml	Edgar Link	unprocessable
hcat-20190630_lab.xml	Edgar Link	unprocessable
hcat-20190630_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HCAT
Health Catalyst, Inc. Stock $hcat

2019 Q3 Form 10-Q Financial Statement

#000163642219000013 Filed on August 23, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HCAT Health Catalyst, Inc. Stock $hcat

2019 Q3 Form 10-Q Financial Statement

#000163642219000013 Filed on August 23, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HCAT
Health Catalyst, Inc. Stock $hcat